Hematologic Product Applications In Europe

1 applications found

In Europe Available In Europe Near Europe

Safety & efficacy testing solutions for cellular therapies areas

The key FDA’s and EMA’s biosafety concerns (1,2) are the potential for cell based tumorigenicity, immunogenicity, infectious disease, and or genetic modification. Cellular therapies are aimed at specific disease types and to proliferate and differentiate into the desired cell type without causing unnecessary and potentially dangerous proliferation into cancer cells or unwanted immunogenicity causing damage in surrounding ...

ByAlcyomics Ltd. based in Newcastle Upon Tyne, UNITED KINGDOM

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you